Barriers to Patch Testing: Assessing Reimbursement Challenges and Practice Patterns Among Members of the American Contact Dermatitis Society
Bibliographic record
Abstract
Abstract: Background: Allergic contact dermatitis (ACD) affects 15–20% of the population, with patch testing as the best diagnostic tool. However, inappropriate reimbursement models and the absence of a physician work relative value unit create financial disincentives that limit access to patch testing services. Objective: This study assessed patch test utilization among American Contact Dermatitis Society (ACDS) members to identify updated reimbursement models and to explore barriers affecting the availability of patch testing. Methods: A 20-question survey was electronically distributed to ACDS members between December 2024 and January 2025, with questions pertaining to practice type, patch testing patterns, current reimbursement structures, and financial barriers to patch testing administration. Results: Among 76 respondents, 83% were dermatologists, with a median of 14 years in practice. Compensation varied: 41% received no payment beyond evaluation and management codes, and 38% were reimbursed via collections. 42% of respondents never conduct extended patch testing. Additionally, 42% of respondents did not accept Medicaid. Frequently cited barriers included lack of standardized billing and high no-show rates. Conclusions: Administrative and financial challenges continue to hinder patch testing accessibility. Standardized reimbursement models, expanded insurance coverage, and policy reforms may help improve equitable access to this critical diagnostic service, though additional barriers such as provider expertise and geographic distribution might also play important roles.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.004 | 0.016 |
| Meta-epidemiology (narrow) | 0.000 | 0.000 |
| Meta-epidemiology (broad) | 0.000 | 0.001 |
| Bibliometrics | 0.002 | 0.001 |
| Science and technology studies | 0.001 | 0.000 |
| Scholarly communication | 0.001 | 0.001 |
| Open science | 0.001 | 0.001 |
| Research integrity | 0.001 | 0.001 |
| Insufficient payload (model declined to judge) | 0.003 | 0.000 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".